Ferrous gluconate 300

Quick links

Choose a section

Quick links to important sections

Advertisements

Ferrous gluconate 300

Selected form

Advertisements
Advertisements

Method of action: Antianemic

Treatment option:

Advertisements

Overview of Ferrous gluconate 300

Quick Facts Overview

Property Description
Active Ingredient Ferrous gluconate (Fe^2+)
Form Oral tablet, capsule, or liquid elixir
Pharmacological Class Hematinic, Antianemia drug
General Purpose Iron replacement
Origin Synthetic chemical salt

The Identity and Classification of Ferrous Gluconate

Ferrous gluconate 300 mg is an oral iron supplement and is classified pharmacologically as a hematinic or antianemia drug. This preparation is a single-ingredient medication containing the active substance, Ferrous gluconate (Iron(II) gluconate), which is a specific synthetic salt designed for efficient oral delivery. This compound is clinically recognized for its common use in supporting iron levels, with various popular preparations utilizing this identical formulation. The 300 mg strength refers to the total weight of the salt, which provides a defined, smaller quantity of elemental iron (Fe^2+), the necessary mineral component required by the body.

Composition and General Therapeutic Purpose

The general purpose of Ferrous gluconate is to facilitate iron replacement, supporting the body’s fundamental requirement for this essential nutrient. This specific iron salt is utilized due to its favorable absorption characteristics in the gastrointestinal tract. The compound is administered through the oral route in several dosage forms, including the most common oral tablet and capsule, allowing flexibility for different patient groups. The use of this oral iron supplement broadly addresses the body's requirement for a steady supply of this mineral to maintain key functions, such as supporting increased physiological demand.

Regulatory References

  1. Ferrous Gluconate - DailyMed (NIH/FDA)
Advertisements

What side effects are possible with Ferrous gluconate 300?

Possible Side Effects and Safety Information

The safety profile for Ferrous gluconate is structured around the regulatory classification of possible adverse reactions and essential limitations for use. The most frequently documented side effects are categorized under Gastrointestinal Disorders.


Official Adverse Reactions and Frequency

Classification System-Organ Class Documented Adverse Reactions
Common Gastrointestinal Disorders Nausea, vomiting, constipation, diarrhea, abdominal pain, and stool discoloration.
Rare Immune System Disorders Hypersensitivity reactions (e.g., anaphylaxis).

Stool discoloration, appearing as dark or black stools, is a common and expected physiological consequence of oral iron supplementation and is listed in regulatory documentation.


Critical Safety Constraints and Warnings

Serious Adverse Reactions

The most critical safety concern is the high risk of acute iron poisoning and resulting severe toxicity, specifically if the medicine is accidentally ingested by children under six years of age. Hypersensitivity reactions are also listed as rare but serious possibilities.

Safety Restrictions (Contraindications)

Ferrous gluconate is contraindicated in individuals with existing conditions of iron overload, such as hemochromatosis or hemosiderosis, or in cases of anemia not caused by iron deficiency, including hemolytic or megaloblastic anemias. Use in these situations is restricted by official regulatory labels.

Time-Related Patterns

Regulatory safety notes indicate that common gastrointestinal side effects, such as nausea and constipation, are often reported to be more pronounced at the initiation of treatment.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for ferrous gluconate overdose emphasizes the serious risk of systemic toxicity. Accidental ingestion of iron-containing products is designated as a leading cause of fatal poisoning in children under 6 years of age, a critical warning that mandates utmost caution.

Documented Manifestations

Overdose typically occurs in two phases. The initial phase is characterized by severe gastrointestinal symptoms resulting from the corrosive action of iron, including nausea, vomiting (which may be bloody or look like coffee grounds), and severe abdominal pain. If toxicity is left unmanaged, the late phase involves systemic effects such as a weak and rapid pulse, dangerously low blood pressure (shock), seizures, and potential progression to coma. Delayed and life-threatening complications can include severe liver failure and kidney damage.

Emergency Actions

Due to the severity and potential for delayed, life-threatening symptoms, regulatory bodies mandate that immediate medical attention must be sought upon known or suspected overdose, even if initial symptoms are mild or absent. It is required to call a Poison Control Center or emergency services immediately. Treatment for severe iron toxicity is symptomatic and supportive and may include the use of the specific iron chelator, Deferoxamine, which binds to excess iron to aid its removal from the body.

Advertisements

Therapeutic Uses of Ferrous gluconate 300

What Ferrous Gluconate 300 Treats: Main Uses and Benefits

Ferrous gluconate is a therapeutic agent commonly used to help with established iron deficiency anemia (IDA) and address iron deficiency without anemia (IDWA). The main therapeutic benefit provides the essential iron to address the mineral deficit, which helps support the physiological function essential for oxygen transport. This action helps manage the most disruptive symptoms related to systemic imbalance, including chronic fatigue, generalized weakness, shortness of breath, and heart palpitations.

This oral supplement is relevant in clinical settings for three primary indications: treating existing iron deficiency, addressing related anemia, and providing supportive nutritional assistance during periods of high physiological demand. The use of oral iron may assist with managing the severe energy drain and is relevant for managing functional instability commonly linked to iron depletion.


Quick Fact: Relief for Chronic Fatigue

Ferrous gluconate assists with maintaining functional stability and contributes to easing the overall symptom load associated with pervasive tiredness. It is applied in addressing symptoms that interfere with daily functioning, such as the inability to sustain physical or cognitive tasks.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Ferrous Gluconate 300

The eligibility for using Ferrous gluconate is determined by specific regulatory criteria, primarily related to a patient’s iron status and certain co-existing medical conditions.


Eligibility Scope

Category Regulatory Status
Populations for whom use is allowed Adults and older adults with established iron deficiency anemia.
Populations for whom use is not recommended Children under 6 years old (due to high fatal overdose risk).
Populations for whom use is contraindicated Patients with iron overload disorders (e.g., hemochromatosis, hemosiderosis), or certain anemias not caused by iron deficiency (e.g., hemolytic anemia).

Eligibility Rules and Restrictions

Age-related eligibility rules: A strict regulatory warning is issued regarding the high risk of fatal accidental poisoning in children under 6 years old. Use in all children often requires consultation with a physician. For older adults, the anemia cause must be assessed, as supplementation may not be appropriate if iron stores are normal.

Condition-specific eligibility rules: The medicine is contraindicated in the presence of active peptic ulceration, ulcerative colitis, or regional enteritis. Caution is also advised for patients with liver problems or alcohol dependence.

Pregnancy and lactation eligibility status: Use is generally considered acceptable during both pregnancy and lactation to address documented iron requirements.

Advertisements

What should I know about interactions with other medicines?

The regulatory interaction profile for ferrous gluconate is primarily defined by its ability to reduce the systemic exposure of numerous co-administered medicinal products, which is a pharmacokinetic interaction.

Interaction Scope

Medicinal product categories with documented interactions: Antibiotics (Fluoroquinolones, Tetracyclines), HIV Antivirals (Integrase Inhibitors), Thyroid Hormones, Bisphosphonates, Parkinson's Disease Agents (Carbidopa, Levodopa), and Gastric Acidity Modifiers (Antacids, Cimetidine, PPIs).

Interaction-related restrictions: Co-administration with Dimercaprol is strictly contraindicated due to the potential for increased nephrotoxic activities. Oral ferrous gluconate is also contraindicated when used with Parenteral Iron preparations.

Timing-based interaction rules: Numerous co-administered drugs require strict timing separation to mitigate the risk of reduced exposure. For instance, Levothyroxine requires a minimum of four hours separation. Tetracycline and Fluoroquinolone antibiotics must be separated by at least two hours from the iron supplement. The HIV antiviral Dolutegravir must be administered two hours before or six hours after the iron product.

Non-Medicinal Product Interactions

Food, alcohol, herbal product interactions: Ferrous gluconate absorption is officially reduced by co-ingestion with dairy products, coffee, and tea. Specific supplements, including Calcium and Zinc, may also decrease absorption.

Connection to the overall interaction profile (2–4 sentences): Official labeling establishes a clear structure of pharmacokinetic constraints where the iron compound reduces the absorption of specific co-administered drugs. This leads to mandatory dose spacing requirements and explicit prohibitions documented by regulatory authorities. The profile also addresses the reduction of iron bioavailability when taken alongside common food components and certain supplements.

Advertisements

Mechanism of Action

Intestinal Uptake and Iron Transport

This mechanistic domain initiates the process by supplying ferrous iron (Fe^2+), which acts as a highly bioavailable substrate. The Fe^2+ is absorbed by specialized carrier proteins, primarily the Divalent Metal Transporter 1 (DMT1), in the intestine. Once absorbed, it is immediately bound to the transport protein transferrin for distribution to the utilization and storage sites within the body.


Hemoglobin Synthesis and Physiological Consequence

The transported iron is delivered to erythroid precursor cells in the bone marrow, where it is structurally incorporated into the protoporphyrin ring to form heme. This process supports the synthesis of functional hemoglobin molecules. The resulting increase in circulating hemoglobin concentration raises the oxygen-carrying capacity of the blood, facilitating systemic oxygen delivery and cellular energy production.


Cofactor Support and Iron Reserve Maintenance

A secondary mechanistic effect involves iron acting as a required cofactor for enzymes, specifically cytochromes involved in cellular respiration. Excess iron is incorporated into the storage protein ferritin in the liver and spleen, establishing physiological iron reserves that contribute to metabolic continuity.

Advertisements

Dosage and Administration Information

Ferrous gluconate is administered exclusively via the oral route in formulations such as tablets, capsules, or liquid elixir. Official dosing for iron replacement is defined by the necessary amount of elemental iron delivered, typically ranging from 60 to 200 mg per day for adult treatment. This total dose is generally prescribed in divided doses up to three times per day to optimize intestinal absorption and manage tolerability.

Administration involves taking the medicine with a full glass of water or juice. While optimal absorption is often achieved when taken on an empty stomach (one hour before or two hours after meals), the medicine may be taken with or after food to minimize common gastrointestinal discomfort. A critical procedural step is the need to separate the intake from certain other medications, such as antacids and specific antibiotics, by at least two hours to prevent chemical interference with iron uptake.

For pediatric patients, dosing is calculated according to body weight, often specified as 3 to 6 mg elemental iron per kilogram of body weight daily. The treatment plan is generally long-term, requiring continuation for approximately three months after the patient's hemoglobin levels have returned to normal to fully replenish iron stores. Specialized forms, such as extended-release tablets, must not be crushed or broken.

Advertisements

Recent Clinical Evidence

Research Evidence: Overview of Studies for Ferrous Gluconate 300

Evidence for Use in Iron Deficiency Anemia (IDA)

The foundational research for iron salts was studied for individuals with established Iron Deficiency Anemia (IDA). This evidence base consists of Randomized Controlled Trials (RCTs) and Systematic Reviews that primarily examined outcomes related to systemic or functional imbalance by measuring objective markers, such as Hemoglobin (Hb) and Serum Ferritin concentrations. Findings describe patterns observed in the studies in which changes were measured in red blood cell status and iron stores in the observed populations. Certain trials also examined patient-reported outcomes describing perceived discomfort, such as fatigue and generalized weakness. The studies contribute to the broader evidence landscape where changes in hematological markers data show patterns related to ferrous iron salts as a class.

Evidence for Use in Iron Deficiency Without Anemia (IDWA)

Ferrous gluconate was evaluated in research exploring individuals identified as having Iron Deficiency Without Anemia (IDWA). The studies for this population include RCTs and Systematic Reviews that research examined outcomes related to systemic or functional imbalance. The main measurement was evaluated in relation to replenishment of Serum Ferritin, as well as the assessment of non-hematological measures. Research has also examined short-term symptom changes through the use of validated patient-reported outcomes, particularly focusing on fatigue scores and outcomes reflecting daily functioning.

Evidence in Special Populations

Ferrous gluconate was evaluated in studies involving several special populations. Specifically, research examined its use in pregnant individuals with iron deficiency, as well as in children and toddlers for the assessment and prevention of iron deficiency. Research examined how symptoms and biomarkers evolved in the observed populations when compared to general adult cohorts. Data for certain groups remain insufficient, particularly for older adults with multiple pre-existing conditions, and sample sizes were modest in many of the specialized trials.

What is Still Uncertain About the Research Base

The research base for Ferrous gluconate, which was evaluated in research exploring iron deficits, still contains several limitations. Long-term effects are not fully established, particularly concerning functional status and symptom measures extending beyond six months. Comparative evidence is lacking for many direct, head-to-head trials against an inactive substance for all clinical endpoints. Ultimately, evidence highlights what is known—and what is still uncertain—and study results reflect the specific conditions under which they were conducted.

Key Studies & References

  1. Iron deficiency anaemia: assessment, counselling and management. NICE guideline [NG205]
  2. Ferrous Gluconate monograph and drug label information
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Ferrous gluconate 300 (FAQ)


Q: What is the difference between ferrous gluconate and ferrous sulfate?

Ferrous gluconate and ferrous sulfate are both types of iron salts used to supplement iron. Compared to ferrous sulfate, ferrous gluconate is sometimes described in medical literature as potentially causing less irritation to the stomach and intestines. This may be due to the fact that it delivers a lower concentration of elemental iron by weight, which may be associated with better tolerability.

Q: Does taking ferrous gluconate cause stomach issues?

Yes, official safety documents list gastrointestinal discomfort as a common adverse reaction to ferrous gluconate. This can include symptoms such as nausea, vomiting, abdominal pain, constipation, and diarrhea. Official documentation notes that administration with or after food is allowed to potentially minimize discomfort.

Q: Is Ferrous gluconate 300 used for all types of anemia?

Official documents specify that ferrous gluconate is used only to treat or prevent iron deficiency anemia. It is explicitly contraindicated, meaning it should not be used, if a patient has anemia caused by something other than a lack of iron, such as hemolytic or megaloblastic anemias.

Q: How long does it take before Ferrous gluconate starts making you feel better?

Clinical literature describes that a hematological response to oral iron typically begins within 3 text to 10 text days. Changes in objective markers of iron improvement, like an increase in hemoglobin, usually take approximately 2 to 4 weeks to be measurable.

Q: Does Ferrous gluconate help with fatigue?

The primary purpose of ferrous gluconate is to treat iron deficiency anemia, a condition often associated with symptoms like fatigue and generalized weakness. By replenishing the body's iron supply, the medication supports the creation of healthy hemoglobin, which improves the blood's oxygen-carrying capacity and may address the systemic lack of oxygen that contributes to fatigue.

Q: Is Ferrous gluconate 300 considered a strong iron supplement?

The 300 mg refers to the total weight of the iron salt (ferrous gluconate), not the amount of pure, usable iron. The actual usable strength of the supplement is based on the elemental iron content, which is a smaller amount. Official guidance on iron replacement uses the elemental iron amount to define the daily dosage strength.

Q: Has Ferrous gluconate been studied in children?

Yes. Official regulatory documents include specific dosing instructions for pediatric patients, with the amount calculated based on body weight. However, due to a high risk of fatal poisoning, the medication must always be kept out of the sight and reach of young children.

Q: What happens if you miss a day of taking Ferrous gluconate?

General instructions found in regulatory patient information advise taking the missed dose as soon as it is remembered. If it is almost time for the next scheduled dose, the missed dose is generally skipped to avoid a double dose. Official guidance strongly cautions against taking a double dose.

Q: Does Ferrous gluconate help with hair loss related to low iron?

Ferrous gluconate is indicated for treating iron deficiency. Since a lack of sufficient iron is known to be associated with non-hematological symptoms, including hair loss, correcting the underlying deficiency may support the resolution of these associated symptoms.

Q: Are there any common skin reactions to Ferrous gluconate?

Official regulatory product information lists hypersensitivity reactions, such as anaphylaxis, as a rare adverse reaction under Immune System Disorders. Other common or non-serious skin reactions are not typically noted in the product's official safety profile.

Q: Is it safe to take Ferrous gluconate if you have a kidney condition?

While ferrous gluconate is not generally prohibited for patients with kidney conditions, its use requires careful assessment of the cause of the anemia. Anemia in patients with chronic kidney disease (CKD) can have complex causes beyond simple iron deficiency, and use in these patients may require monitoring to ensure iron stores are appropriate.

Q: Can Ferrous gluconate cause headaches or dizziness?

Official product labeling primarily lists gastrointestinal issues as common side effects. However, headaches and dizziness are occasionally noted in the broader medical literature concerning oral iron supplementation.

Q: Is the absorption rate of Ferrous gluconate better than other iron salts?

Ferrous iron salts, including ferrous gluconate, are generally preferred over ferric salts because of their established absorption characteristics in the intestine. For comparisons against other specific ferrous salts, the focus is usually on patient tolerability rather than major differences in absorption rates.

Q: Is Ferrous gluconate used for Restless Legs Syndrome?

The primary indication for ferrous gluconate in regulatory documents is the treatment of iron deficiency. However, some clinical research has explored the use of iron supplements to help individuals with Restless Legs Syndrome (RLS) who also have low iron stores, specifically low serum ferritin levels.

Q: Why is Ferrous gluconate sometimes described as gentler on the stomach?

The description 'gentler on the stomach' is often used in comparison to other iron salts. This is because ferrous gluconate delivers a smaller amount of elemental iron per tablet, potentially leaving less unabsorbed iron in the intestines. Less unabsorbed iron in the gut may be a factor in potentially better gastrointestinal tolerability.

Q: What should I do if I think I have had too much Ferrous gluconate?

Official warnings emphasize that accidental overdose of iron products is a leading cause of fatal poisoning in young children. In the event of a suspected or known overdose, immediate emergency medical attention is advised. You should contact a poison control center immediately.

Q: Can I take Ferrous gluconate with coffee or tea?

Official regulatory warnings indicate that co-ingestion with common beverages, specifically coffee and tea, significantly reduces the absorption of ferrous gluconate. This interaction may reduce the amount of iron absorbed by the body.

Q: How is Ferrous gluconate processed by the body?

The ferrous iron (Fe^2+) is absorbed primarily in the small intestine using specialized transport proteins. Once absorbed, the iron is bound to a protein called transferrin for distribution throughout the body. Excess iron is incorporated into the storage protein ferritin, mainly in the liver and spleen, to create physiological iron reserves.

Q: Are there specific demographics where Ferrous gluconate is more commonly used?

Official documents highlight the use of iron supplementation in populations that have high physiological iron requirements or high rates of deficiency. This includes pregnant individuals, women of child-bearing age (due to menstrual blood loss), and growing children.

Q: What are the main ingredients in Ferrous gluconate 300 tablets?

The main ingredient is the active substance, Ferrous gluconate. Like all tablets and capsules, the product also contains various inactive ingredients, or excipients, which can include items such as cellulose, silicone dioxide, stearic acid, and colorants, all of which are documented on the official product labeling.

Q: Does Ferrous gluconate interact with calcium supplements?

Yes, co-ingestion with certain other supplements, including calcium, may decrease the absorption of ferrous gluconate into the bloodstream. Because of this chemical interference, official labeling requires a specific time separation between taking the iron supplement and the calcium supplement.

Q: Can Ferrous gluconate cause heartburn?

Heartburn is a form of gastrointestinal discomfort. Since the drug's official label lists several gastrointestinal disorders, such as nausea and abdominal pain, as common side effects, heartburn is a related and possible symptom that may be experienced during treatment.

Q: Can Ferrous gluconate be taken during pregnancy?

Yes. Official regulatory documents state that the use of ferrous gluconate is generally considered acceptable during both pregnancy and lactation. This is often necessary to address the increased iron requirements needed during these times.

Q: What foods or drinks can interfere with Ferrous gluconate absorption?

Official regulatory warnings state that absorption is significantly reduced by co-ingestion with dairy products, coffee, and tea. Specific supplements, including Calcium and Zinc, may also decrease the absorption of the iron.

Q: Can Ferrous gluconate be crushed or split?

Instructions vary based on the specific formulation. For many tablets, official documents state 'Do not crush or chew tablets.' For extended-release or slow-release forms, it is explicitly warned that they must not be crushed or broken as this can affect the rate of absorption and increase the risk of side effects.

Q: Do I need to get my blood tested while taking Ferrous gluconate?

Monitoring iron status markers is common to assess the treatment's impact and effectiveness. Regulatory documents state that treatment is generally long-term and must be continued until iron stores are fully replenished, which is often judged by monitoring markers like hemoglobin and ferritin levels.

Q: What is the recommended duration for taking Ferrous gluconate 300?

Official documents state that treatment is generally long-term. The recommended duration requires continuation for approximately three months after a patient’s hemoglobin levels have returned to normal to ensure that deep iron reserves in the body are fully replenished.

Advertisements

How should Ferrous gluconate 300 be stored and disposed of?

How to Store and Dispose of Ferrous gluconate 300

The storage and disposal requirements for Ferrous gluconate are strictly defined in regulatory labeling to ensure product stability and household safety.

Storage Requirements

Ferrous gluconate must be stored at Controlled Room Temperature (CRT), which is between 20 C and 25 C (68 F and 77 F), with permitted fluctuations up to 30 C. The product must be protected from excessive moisture and humidity, and must be kept in its original container, which should be tightly closed when not in use. Stability is maintained when these conditions are met until the product's expiration date.

Child Safety and Disposal

It is mandatory to keep this product out of the sight and reach of children at all times. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Unused or expired medication must not be thrown in household trash or flushed down the toilet. Disposal must follow the specific local regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ferrous gluconate 300 found in:

A-Z Index: